AN1
Click for more information
0.00% 0.7¢ anagenics limited

midkine antibodies effective in cancer, page-10

  1. malmanu
    16,381 Posts.
    lightbulb Created with Sketch. 761
    clock Created with Sketch.
    03/10/13
    10:54
    Post #: 12401991
    Its a pre-clinical result , dont mean much until they do actual trials. Other bio's with actual results from trials in progress dont even get this sort of reaction. Its an over reaction imo.
    CDY Price at posting: 3.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $350 50K

Buyers (Bids)

No. Vol. Price($)
4 775527 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 5022 1
View Market Depth
Last trade - 11.14am 09/08/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.